Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Fox

Showing results (61-70 of 491) with videos related to

Pageof 50
Sort By:
Circulation|May 22, 2020
The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular DiseaseJan Steffel, John W Eikelboom, Sonia S Anand, et al.
Circulation|April 30, 2019
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery DiseasePaul A Gurbel, Keith A A Fox, Udaya S Tantry, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2003
Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humansStanley Chia, Motaz Qadan, Richard Newton, et al.
Expert Opinion on Investigational Drugs|May 22, 2008
Rivaroxaban, an oral direct factor Xa inhibitorJonathan P Piccini, Manesh R Patel, Kenneth W Mahaffey, et al.
Cardiovascular Research|August 12, 2003
Influence of differential vascular remodeling on the coronary vasomotor responseAndrew L McLeod, David E Newby, David B Northridge, et al.
International Journal of Cardiology|December 13, 2018
The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI populationFrançois Schiele, Etienne Puymirat, Jean Ferrières, et al.
Journal of the American College of Cardiology|May 11, 2019
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS TrialKeith A A Fox, John W Eikelboom, Olga Shestakovska, et al.
Circulation|February 4, 2010
Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromesClara K Chow, Sanjit Jolly, Purnima Rao-Melacini, et al.
Perfusion|October 10, 2013
Restoration of the coagulation cascade on CPB: a case reportK J Lilly, P A Pirundini, A A Fox, et al.
Circulation|August 16, 2006
Adverse impact of bleeding on prognosis in patients with acute coronary syndromesJohn W Eikelboom, Shamir R Mehta, Sonia S Anand, et al.
Pageof 50

Showing results (61-70 of 491) with videos related to

Sort By:
Pageof 50
Circulation|May 22, 2020
The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular DiseaseJan Steffel, John W Eikelboom, Sonia S Anand, et al.
Circulation|April 30, 2019
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery DiseasePaul A Gurbel, Keith A A Fox, Udaya S Tantry, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2003
Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humansStanley Chia, Motaz Qadan, Richard Newton, et al.
Expert Opinion on Investigational Drugs|May 22, 2008
Rivaroxaban, an oral direct factor Xa inhibitorJonathan P Piccini, Manesh R Patel, Kenneth W Mahaffey, et al.
Cardiovascular Research|August 12, 2003
Influence of differential vascular remodeling on the coronary vasomotor responseAndrew L McLeod, David E Newby, David B Northridge, et al.
International Journal of Cardiology|December 13, 2018
The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI populationFrançois Schiele, Etienne Puymirat, Jean Ferrières, et al.
Journal of the American College of Cardiology|May 11, 2019
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS TrialKeith A A Fox, John W Eikelboom, Olga Shestakovska, et al.
Circulation|February 4, 2010
Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromesClara K Chow, Sanjit Jolly, Purnima Rao-Melacini, et al.
Perfusion|October 10, 2013
Restoration of the coagulation cascade on CPB: a case reportK J Lilly, P A Pirundini, A A Fox, et al.
Circulation|August 16, 2006
Adverse impact of bleeding on prognosis in patients with acute coronary syndromesJohn W Eikelboom, Shamir R Mehta, Sonia S Anand, et al.
Pageof 50